Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis

Immunity

Volumn 11, Issue 6, 1999, Pages 709-719

  Shirogane, Takahiro ^a   Fukada, Toshiyuki ^a,c   Muller, Joyce M M ^b   Shima, David T ^b   Hibi, Masahiko ^a   Hirano, Toshio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 6; PROTEIN BCL 2; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STAT3 PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; SIGNAL TRANSDUCTION;

EID: 0033451992     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80145-4     Document Type: Article

References (66)

1. Akira, S. (1999). Functional roles of STAT family proteins: Lessons from knockout mice. Stem Cells 17, 138-146.
2. Allen, J.D., Verhoeven, E., Domen, J., van der Valk, M., and Berns, A. (1997). Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene 15, 1133-1141.
3. Askew, D.S., Ashmun, R.A., Simmons, B.C., and Cleveland, J.L. (1991). Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915-1922.
4. Besser, D., Bromberg, J.F., Darnell, J.E., Jr., and Hanafusa, H. (1999). A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol. Cell. Biol. 19, 1401-1409.
5. Bissonnette, R.P., Echeverri, F., Mahboubi, A., and Green, D.R. (1992). Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359, 552-554.
6. Breuer, M., Slebos, R., Verbeek, S., van Lohuizen, M., Wientjens, E., and Berns, A. (1989). Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature 340, 61-63.
7. Bromberg, J.F., Horvath, C.M., Besser, D., Lathem, W.W., and Darnell, J.E., Jr. (1998). Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18, 2553-2558.
8. Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C., and Darnell, J.E. (1999). Stat3 as an oncogene. Cell 98, 295-303.
9. Carlesso, N., Frank, D.A., and Griffin, J.D. (1996). Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183, 811-820.
10. Catlett-Falcone, R., Landowski, T.H., Oshiro, M.M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernandez-Luna, J.L.,Nunez, G., et al. (1999). Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105-115.
11. Cuypers, H.T., Selten, G., Quint, W., Zijlstra, M., Maandag, E.R., Boelens, W., van Wezenbeek, P., Melief, C., and Berns, A. (1984). Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region. Cell 37, 141-150.
12. Danial, N.N., Pernis, A., and Rothman, P.B. (1995). Jak-STAT signaling induced by the v-abl oncogene. Science 269, 1875-1877.
13. Domen, J., van der Lugt, N.M., Acton, D., Laird, P.W., Linders, K., and Berns, A. (1993a). Pim-1 levels determine the size of early B lymphoid compartments in bone marrow. J. Exp. Med. 178, 1665-1673.
14. Domen, J., van der Lugt, N.M., Laird, P.W., Saris, C.J., and Berns, A. (1993b). Analysis of Pim-1 function in mutant mice. Leukemia 7, S108-S112.
15. Domen, J., van der Lugt, N.M., Laird, P.W., Saris, C.J., Clarke, A.R., Hooper, M.L., and Berns, A.(1993c). Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells. Blood 82,1445-1452.
16. Egerton, M., Ashe, O.R., Chen, D., Druker, B.J., Burgess, W.H., and Samelson, L.E. (1992). VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell antigen receptor activation. EMBO J. 11, 3533-3540.
17. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z., and Hancock, D.C. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128.
18. Frohlich, K.U., Fries, H.W., Rudiger, M., Erdmann, R., Botstein, D., and Mecke, D. (1991). Yeast cell cycle protein CDC48p shows full-length homology to the mammalian protein VCP and is a member of a protein family involved in secretion, peroxisome formation, and gene expression. J. Cell. Biol. 114, 443-453.
19. Frohlich, K.U., Fries, H.W., Peters, J.M., and Mecke, D. (1995). The ATPase activity of purified CDC48p from Saccharomyces cerevisiae shows complex dependence on ATP-, ADP-, and NADH-concentrations and is completely inhibited by NEM. Biochim. Biophys. Acta 1253, 25-32.
20. Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K., and Hirano, T. (1996). Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 5, 449-460.
21. Fukada, T., Ohtani, T., Yoshida, Y., Shirogane, T., Nishida, K., NakaJima, K., Hibi, M., and Hirano, T. (1998). STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J. 17, 6670-6677.
22. Galaktionov, K., Chen, X., and Beach, D. (1996). Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382, 511-517.
23. Hilbert, D.M., Mignone, T.S., Kopf, M., Leonard, W.J., and Rudikoff, S. (1996). Distinct tumorigenic potential of abl and raf in B cell neuroplasia: Abl activates the IL-6 signaling pathway. Immunity 5, 81-89.
24. Hirano, T., Nakajima, K., and Hibi, M. (1997). Signaling mechanisms through gp130: A model of the cytokine system. Cytokine Growth Factor Rev. 8, 241-252.
25. Jaster, R., Tschirch, E., Bittorf, T., and Brock, J. (1999). Role of STAT5 in interferon-alpha signal transduction in Ba/F3 cells. Cell Signal 11, 331-335.
26. Kagaya, S., Kitanaka, C., Noguchi, K., Mochizuki, T., Sugiyama, A., Asai, A., Yasuhara, N., Eguchi, Y., Tsujimoto, Y., and Kuchino, Y. (1997). A functional role for death proteases in s-Myc- and c-Myc-mediated apoptosis. Mol. Cell. Biol. 17, 6736-6745.
27. Kaplan, M.H., Sun, Y.L., Hoey, T., and Grusby, M.J. (1996). Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177.
28. Keath, E.J., Kelekar, A., and Cole, M.D. (1984). Transcriptional activation of the translocated c-myc oncogene in mouse plasmacytomas: Similar RNA levels in tumor and proliferating normal cells. Cell 37, 521-528.
29. Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C., Lubbert, H., and Bujard, H. (1996). Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93, 10933-10938.
30. Kiuchi, N., Nakajima, K., Ichiba, M., Fukada, T., Narimatsu, M., Mizuno, K., Hibi, M., and Hirano, T. (1999). STAT3 is required for the gp130-mediated full activation of the c-myc gene. J. Exp. Med. 189, 63-73.
31. Konietzko, U., Kauselmann, G., Scafidi, J., Staubli, U., Mikkers, H., Berns, A., Schweizer, M., Waltereit, R., and Kuhl, D. (1999). Pim kinase expression is induced by LTP stimulation and required for the consolidation of enduring LTP. EMBO J. 18, 3359-3369.
32. Krumenacker, J.S., Buckley, D.J., Leff, M.A., McCormack, J.T., de Jong, G., Gout, P.W., Reed, J.C., Miyashita, T., Magnuson, N.S., and Buckley, A.R. (1998). Prolactin-regulated apoptosis of Nb2 lymphoma cells: Pim-1, bcl-2, and bax expression. Endocrine 9, 163-170.
33. Lilly, M., and Kraft, A. (1997). Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells. Cancer Res. 57, 5348-5355.
34. Lilly, M., Le, T., Holland, P., and Hendrickson, S.L. (1992). Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related. Oncogene 7, 727-732.
35. Madeo, F., Frohlich, E., and Frohlich, K.U. (1997). A yeast mutant showing diagnostic markers of early and late apoptosis. J. Cell. Biol. 139, 729-734.
36. Matikainen, S., Sareneva, T., Ronni, T., Lehtonen, A., Koskinen, P.J., and Julkunen, I. (1999). Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood 93, 1980-1991.
37. Mignone, T.S., Lin, J.X., Cereseto, A., Mulloy, J.C., O'Shea, J.J., Franchini, G., and Leonard, W.J. (1995). Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science 269 79-81.
38. Miyazaki, T., Liu, Z.J., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E.L., Permutter, R.M., and Taniguchi, T. (1995). Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and Ick cooperate in hematopoietic cell proliferation. Cell 81, 223-231.
39. Mochizuki, T., Kitanaka, C., Noguchi, K., Muramatsu, T., Asai, A., and Kuchino, Y. (1999). Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J. Biol. Chem. 274, 18659-18666.
40. Moriggl, R., Topham, D.J., Teglund, S., Sexl, V., McKay, C., Wang, D., Hoffmeyer, A., van Deursen, J., Sangster, M.Y., Bunting, K.D., et al. (1999). Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10, 249-259.
41. Mui, A.L., Wakao, H., Kinoshita, T., Kitamura, T., and Miyajima, A. (1996). Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: Role of Stat5 in proliferation. EMBO J. 15, 2425-2433.
42. Muller, J.M., Meyer, H.H., Ruhrberg, C., Stamp, G.W., Warren, G., and Shima, D.T. (1999). The mouse p97 (CDC48) gene. Genomic structure, definition of transcriptional regulatory sequences, gene expression, and characterization of a pseudogene. J. Biol. Chem. 274, 10154-10162.
43. Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., and Hirano, T. (1996). A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15, 3651-3658.
44. Nishida, K., Yoshida, Y., Itoh, M., Fukada, T., Ohtani, T., Shirogane, T., Atsumi, T., Takahashi-Tezuka, M., Ishihara, K., Hibi, M., et al. (1999). Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors. Blood 93, 1809-1816.
45. Nosaka, T., Kawashima, T., Misawa, K., Ikuta, K., Mui, A.L., and Kitamura, T. (1999). STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 18, 4754-4765.
46. Sakai, I., and Kraft, A.S. (1997). The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells. J. Biol. Chem. 272, 12350-12358.
47. Saris, C.J., Domen, J., and Berns, A. (1991). The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J. 10, 655-664.
48. Sato, N., Sakamaki, K., Terada, N., Arai, K., and Miyajima, A. (1993). Signal transduction by the high-affinity GM-CSF receptor: Two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J. 12, 4181-4189.
49. Schmidt, T., Karsunky, H., Gau, E., Zevnik, B., Elsasser, H.P., and Moroy, T. (1998). Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene 17, 2661-2667.
50. Selten, G., Cuypers, H.T., Boelens, W., Robanus-Maandag, E., Verbeek, J., Domen, J., van Beveren, C., and Berns, A. (1986). The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases. Cell 46, 603-611.
51. Shimizu, S., Eguchi, Y., Kamiike, W., Itoh, Y., Hasegawa, J., Yamabe, K., Otsuki, Y., Matsuda, H., and Tsujimoto, Y. (1996). Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res. 56, 2161-2166.
52. Socolovsky, M., Fallon, A.E., Wang, S., Brugnara, C., and Lodish, H.F. (1999). Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: A direct role for Stat5 in Bcl-X(L) induction. Cell 98, 181-191.
53. Stahl, N., Farruggella, T.J., Boulton, T.G., Zhong, Z., Darnell, J.E., Jr., and Yancopoulos, G.D. (1995). Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267, 1349-1353.
54. Takahashi-Tezuka, M., Yoshida, Y., Fukada, T., Ohtani, T., Yamanaka, Y., Nishida, K., Nakajima, K., Hibi, M., and Hirano, T. (1998). Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol. Cell. Biol. 18, 4109-4107.
55. Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S., Nakanishi, K., Yoshida, N., Kishimoto, T., and Akira, S. (1996). Essential role of Stat6 in IL-4 signaling. Nature 380, 627-630.
56. Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., and Akira, S. (1998). Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161, 4652-4660.
57. Thierfelder, W.E., van Deursen, J.M., Yamamoto, K., Tripp, R.A., Sarawar, S.R., Carson, R.T., Sangster, M.Y., Vignali, D.A., Doherty, P.C., Grosveld, G.C., et al. (1996). Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174.
58. Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., DeGroot, R.P., and Jove, R. (1998). Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18, 2545-2552.
59. van der Lugt, N.M., Domen, J., Verhoeven, E., Linders, K., van der Gulden, H., Allen, J., and Berns, A. (1995). Proviral tagging in E mumyc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J. 14, 2536-2544.
60. van Lohuizen, M., Verbeek, S., Krimpenfort, P., Domen, J., Saris, C., Radaszkiewicz, T., and Berns, A. (1989). Predisposition to lympho-magenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 56, 673-682.
61. van Lohuizen, M., Verbeek, S., Scheijen, B., Wientjens, E., van der Gulden, H., and Berns, A. (1991). Identification of cooperating oncogenes in E μ-myc transgenic mice by provirus tagging. Cell 65, 737-752.
62. Wagner, A.J., Small, M.B., and Hay, N. (1993). Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol. Cell. Biol. 13, 2432-2440.
63. Wu, D., Chen, P.J., Chen, S., Hu, Y., Nunez, G., and Ellis, R.E. (1999). C. elegans MAC-1, an essential member of the AAA family of ATPases, can bind CED-4 and prevent cell death. Development 126, 2021-2031.
64. Xu, X., Sun, Y.L., and Hoey, T. (1996). Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273, 794-797.
65. Yamanaka, Y., Nakajima, K., Fukada, T., Hibi, M., and Hirano, T. (1996). Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J. 15, 1557-1565.
66. Yu, C.L., Meyer, D.J., Campbell, G.S., Larner, A.C., Carter-Su, C., Schwartz, J., and Jove, R. (1995). Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269, 81-83.